Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera

Saved in:
Bibliographic Details
Title: Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera
Authors: Wernig, Gerlinde1, Kharas, Michael G.1, Okabe, Rachel1, Moore, Sandra A.1, Leeman, Dena S.1, Cullen, Dana E.1, Gozo, Maricel1, McDowell, Elizabeth P.1, Levine, Ross L.1,2, Doukas, John3, Mak, Chi Ching3, Noronha, Glenn3, Martin, Michael3, Ko, Yon D.4, Lee, Benjamin H.1, Soll, Richard M.3, Tefferi, Ayalew5, Hood, John D.3, Gilliland, D. Gary1,6,7 ggilliland@rics.bwh.harvard.edu
Source: Cancer Cell. Apr2008, Vol. 13 Issue 4, p311-320. 10p.
Database: Academic Search Ultimate
Description
ISSN:15356108
DOI:10.1016/j.ccr.2008.02.009